Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.

  • Guy Chouinard
  • Published 2004 in The Journal of clinical psychiatry


Low and medium potency benzodiazepines were initially introduced for the treatment of insomnia and anxiety. Their therapeutic actions as anxiolytics, sedative hypnotics, anticonvulsants, and muscle relaxants (with their low toxicity) have led to their use as first-line treatments, and they have become one of the most prescribed classes of drugs. Novel… (More)


  • Presentations referencing similar topics